Literature DB >> 6932090

In vitro development of chlorhexidine resistance in Streptococcus sanguis and its transmissibility by genetic transformation.

G Westergren, C G Emilson.   

Abstract

Three chlorhexidine-sensitive strains of Streptococcus sanguis developed resistance to chlorhexidine when grown as continuous cultures in a fermenter containing medium with increasing concentrations of the drug. The MIC of the test strains increased by between two and three dilution steps and these high values were maintained after daily transfer in drug-free medium for at least 15 d. In addition, the resistance of one of the strains persisted for more than 1 month of continuous growth in drug-competent sensitive S. sanguis to increased chlorhexidine resistance, thus proving that resistance to this drug is an inheritable trait. Immunoelectrophoretic experiments showed that certain changes in the antigenic pattern of the Chxr variants had occurred as compared with their sensitive wild-type strains. Antigenic extracts of the Chxr variants and all Chxr recombinants tested contained consistently less protein than those of the sensitive wild-types.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6932090     DOI: 10.1111/j.1600-0722.1980.tb01220.x

Source DB:  PubMed          Journal:  Scand J Dent Res        ISSN: 0029-845X


  11 in total

1.  Skin bacteria after chlorhexidine exposure-is there a difference in response to human beta-Defensin-3?

Authors:  M Reichel; A Heisig; P Heisig; G Kampf
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-27       Impact factor: 3.267

Review 2.  Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs.

Authors:  Günter Kampf; Axel Kramer
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 3.  Cetylpyridinium Chloride: Mechanism of Action, Antimicrobial Efficacy in Biofilms, and Potential Risks of Resistance.

Authors:  Xiaojun Mao; David L Auer; Wolfgang Buchalla; Karl-Anton Hiller; Tim Maisch; Elmar Hellwig; Ali Al-Ahmad; Fabian Cieplik
Journal:  Antimicrob Agents Chemother       Date:  2020-07-22       Impact factor: 5.191

4.  In vitro susceptibility of Streptococcus mutans to chlorhexidine and six other antimicrobial agents.

Authors:  H Järvinen; J Tenovuo; P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

5.  The study of release of chlorhexidine from preparations with modified thermosensitive poly-N-isopropylacrylamide microspheres.

Authors:  Witold Musial; Bojana Voncina; Janusz Pluta; Vanja Kokol
Journal:  ScientificWorldJournal       Date:  2012-04-26

6.  Efficacy of two distinct ethanol-based hand rubs for surgical hand disinfection -- a controlled trial according to prEN 12791.

Authors:  Günter Kampf; Christiane Ostermeyer
Journal:  BMC Infect Dis       Date:  2005-03-22       Impact factor: 3.090

7.  Reduced Chlorhexidine and Daptomycin Susceptibility in Vancomycin-Resistant Enterococcus faecium after Serial Chlorhexidine Exposure.

Authors:  Pooja Bhardwaj; Amrita Hans; Kinnari Ruikar; Ziqiang Guan; Kelli L Palmer
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

8.  Development of antiseptic adaptation and cross-adapatation in selected oral pathogens in vitro.

Authors:  Tim Verspecht; Esteban Rodriguez Herrero; Ladan Khodaparast; Laleh Khodaparast; Nico Boon; Kristel Bernaerts; Marc Quirynen; Wim Teughels
Journal:  Sci Rep       Date:  2019-06-06       Impact factor: 4.379

9.  Catechin-incorporated dental copolymers inhibit growth of Streptococcus mutans.

Authors:  Alexandra Mankovskaia; Céline M Lévesque; Anuradha Prakki
Journal:  J Appl Oral Sci       Date:  2013 Mar-Apr       Impact factor: 2.698

10.  Dental plaque bacteria with reduced susceptibility to chlorhexidine are multidrug resistant.

Authors:  Hafiz Ghulam Murtaza Saleem; Christine Ann Seers; Anjum Nasim Sabri; Eric Charles Reynolds
Journal:  BMC Microbiol       Date:  2016-09-15       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.